Search for: "Novartis Pharmaceuticals Corporation" Results 1 - 20 of 155
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jul 2020, 1:00 pm by Tom Lamb
These cases are being investigated as potential drug injury lawsuits against Novartis Pharmaceuticals Corporation, the drug company responsible for Beovu here in the US. [read post]
22 Jul 2020, 7:18 am by Jonathan Tycko
Department of Justice (DOJ) recently announced that a major pharmaceutical company, Novartis Pharmaceuticals, agreed to pay $642 million to settle a lawsuit alleging that Novartis violated the False Claims Act (FCA). [read post]
13 Jul 2020, 12:59 pm by Peter Briccetti
On July 1, Novartis Pharmaceuticals Corporation agreed to pay $642 million to settle a False Claims Act case brought by a whistleblower. [read post]
2 Jul 2020, 8:41 am by anne
Novartis Foreign Bribery Scheme Novartis AG, the Novartis parent company based in Switzerland, and former Novartis subsidiary Alcon Pte Ltd were alleged to have violated the Foreign Corrupt Practices Act by bribing officials in, respectively, Greece and Vietnam to induce the purchase of Novartis-branded pharmaceuticals and Alcon surgical products, and then falsifying their corporate books and records to conceal the bribes. [read post]
25 Jun 2020, 12:07 pm by Mary Jane Wilmoth
Department of Justice (DOJ) announced Novartis AG (“Novartis”), a global pharmaceutical and healthcare company based in Switzerland, agreed to pay over $225 million to resolve FCPA charges for bribery in Greece. [read post]
24 Apr 2020, 5:24 am by Lawrence B. Ebert
(collectively, Apotex) filed a petition for inter partes reviewof Novartis Pharmaceuticals Corporation’s U.S. [read post]
3 Mar 2020, 4:00 am by Alan Macek
In Novartis Pharmaceuticals Canada Inc. v. [read post]
30 Jan 2020, 10:49 am by luiza
  Correctional facilities operators Management and Training Corporation, Cornell Companies, Inc. [read post]
24 Jan 2020, 10:24 am by luiza
  Also tagged in this scheme were Novartis, Dendreon, Onyx, Questcor, and Bayer. [read post]
19 Dec 2019, 12:23 pm by Tom Lamb
As an aside, one wonders why there has been no FDA action regarding this Gilenya birth defects issue and why there has been no "Dear Doctor Letter" about pregnant women using Gilenya sent out by Novartis Pharmaceuticals Corporation in the US as of this date (i.e., December 19, 2019). [read post]
29 Oct 2019, 10:48 am by Jeffrey A. Newman
Braun Medical Inc.; Forest Laboratories, Inc.; GlaxoSmithKline LLC; Johnson & Johnson, Inc.; Janssen Pharmaceutical Products, LP; McNeil-PPC, Inc.; Ortho Biotech Products, LP; Ortho-McNeil Pharmaceutical, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Pharmacia Corporation; and TAP Pharmaceutical Products, Inc. [read post]
27 Jun 2019, 5:50 pm by Stuart P. Meyer
Back in March, I reported on the breadth of comments the USPTO received in response to its new Guidance on patent subject matter eligibility. [read post]
26 Mar 2019, 1:59 pm by Stuart P. Meyer
The Pharmaceutical Research and Manufacturers of America specifically praised various aspects of the Guidance for providing clarity in areas that had been confusing. [read post]
7 Dec 2018, 2:23 pm by Lawrence B. Ebert
The outcome was reversal; Novartis wins:Novartis Pharmaceuticals Corporation and NovartisAG (collectively, Novartis) appeal the district court’sdecision to invalidate U.S. [read post]
16 May 2018, 7:17 pm by Sabrina I. Pacifici
The document detailed sums in the hundreds of thousands of dollars paid to Cohen by the pharmaceutical company Novartis, the telecommunications giant A.T. [read post]
11 May 2018, 8:59 am by Joe Consumer
We got word that a couple weeks ago, the Swiss pharmaceutical giant, Novartis, was about to change its company profile page! [read post]
6 Mar 2018, 2:10 pm by Tom Lamb
In closing this article, I will point out that in the US there still has not been any "Dear Doctor" letter sent nor any Tasigna drug label change made by Novartis Pharmaceuticals Corporation regarding atherosclerosis, despite the actions taken by its Canadian counterpart during April 2013. [read post]
6 Mar 2018, 2:10 pm by Tom Lamb
In closing this article, I will point out that as of today, nearly five years after the actions taken by Novartis Pharmaceuticals Canada Inc., in the US there still has not been any "Dear Doctor" letter nor any Tasigna drug label change made by Novartis Pharmaceuticals Corporation similar to what was done in Canada during April 2013. [read post]